224 related articles for article (PubMed ID: 8903635)
1. Effects of arginine vasopressin and 1-desamino-8-D arginine vasopressin on forearm vasculature of healthy subjects and patients with a V2 receptor defect.
van Lieburg AF; Knoers NV; Monnens LA; Smits P
J Hypertens; 1995 Dec; 13(12 Pt 2):1695-700. PubMed ID: 8903635
[TBL] [Abstract][Full Text] [Related]
2. The effect of arginine vasopressin on endothelin production in the human forearm vascular bed.
Postma CT; Maessen SM; Thien T; Smits P
Neth J Med; 2005 Jun; 63(6):199-204. PubMed ID: 16011011
[TBL] [Abstract][Full Text] [Related]
3. Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo.
Seddon MD; Chowienczyk PJ; Brett SE; Casadei B; Shah AM
Circulation; 2008 Apr; 117(15):1991-6. PubMed ID: 18391107
[TBL] [Abstract][Full Text] [Related]
4. Forearm vasoconstriction in response to noradrenaline and NG-monomethyl-L-arginine in essential hypertension.
Kneale BJ; Chowienczyk PJ; Brett SE; Cockcroft JR; Ritter JM
Clin Sci (Lond); 1999 Sep; 97(3):277-82. PubMed ID: 10464052
[TBL] [Abstract][Full Text] [Related]
5. Abnormal desmopressin-induced forearm vasodilatation in patients with heart failure: dependence on nitric oxide synthase activity.
Rector TS; Bank AJ; Tschumperlin LK; Mullen KA; Lin KA; Kubo SH
Clin Pharmacol Ther; 1996 Dec; 60(6):667-74. PubMed ID: 8988069
[TBL] [Abstract][Full Text] [Related]
6. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
7. Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.
Cockcroft JR; Chowienczyk PJ; Brett SE; Chen CP; Dupont AG; Van Nueten L; Wooding SJ; Ritter JM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1067-71. PubMed ID: 7562470
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis.
Campillo B; Chabrier PE; Pelle G; Sediame S; Atlan G; Fouet P; Adnot S
Hepatology; 1995 Nov; 22(5):1423-9. PubMed ID: 7590658
[TBL] [Abstract][Full Text] [Related]
9. Peripheral endothelial dysfunction in normal pressure glaucoma.
Henry E; Newby DE; Webb DJ; O'Brien C
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1710-4. PubMed ID: 10393040
[TBL] [Abstract][Full Text] [Related]
10. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
Calver A; Collier J; Moncada S; Vallance P
J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
[TBL] [Abstract][Full Text] [Related]
11. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
[TBL] [Abstract][Full Text] [Related]
13. The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes.
Wotherspoon F; Browne DL; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
Diabet Med; 2005 Jun; 22(6):697-702. PubMed ID: 15910619
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial vasopressin in the human forearm: pharmacodynamics and the role of nitric oxide.
Affolter JT; McKee SP; Helmy A; Jones CR; Newby DE; Webb DJ
Clin Pharmacol Ther; 2003 Jul; 74(1):9-16. PubMed ID: 12844130
[TBL] [Abstract][Full Text] [Related]
15. Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole.
Passauer J; Büssemaker E; Lässig G; Pistrosch F; Fauler J; Gross P; Fleming I
Clin Sci (Lond); 2003 Oct; 105(4):513-8. PubMed ID: 12826020
[TBL] [Abstract][Full Text] [Related]
16. Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol.
Woodman RJ; Playford DA; Watts GF
Diabetes Res Clin Pract; 2006 Jan; 71(1):59-67. PubMed ID: 16029909
[TBL] [Abstract][Full Text] [Related]
17. Direct biochemical evidence for eNOS stimulation by bradykinin in the human forearm vasculature.
Lauer T; Kleinbongard P; Preik M; Rauch BH; Deussen A; Feelisch M; Strauer BE; Kelm M
Basic Res Cardiol; 2003 Mar; 98(2):84-9. PubMed ID: 12607129
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous vascular response to vasopressin: radial artery versus forearm blood flow.
Hayoz D; Weber R; Pechère A; Burnier M; Brunner HR
J Hypertens; 1997 Jan; 15(1):35-41. PubMed ID: 9050968
[TBL] [Abstract][Full Text] [Related]
19. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
Pickkers P; Dorresteijn MJ; Bouw MP; van der Hoeven JG; Smits P
Circulation; 2006 Aug; 114(5):414-21. PubMed ID: 16864730
[TBL] [Abstract][Full Text] [Related]
20. Inducible nitric oxide synthase activity does not contribute to the maintenance of peripheral vascular tone in patients with heart failure.
Dover AR; Chia S; Ferguson JW; Cruden NL; Megson IL; Fox KA; Newby DE
Clin Sci (Lond); 2006 Oct; 111(4):275-80. PubMed ID: 16803456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]